Getty Images

BLOCKBUSTER: Chris Sale traded to the Red Sox for Yoan Moncada, Michael Kopech, prospects


OXON HILL, MD — A huge trade just went down between the Red Sox and White Sox. Ken Rosenthal reports that the Red Sox have acquired White Sox starter Chris Sale in exchange for top prospects Yoan Moncada and Michel Kopech, along with two other prospects: Victor Diaz, a single-A pitcher and Luis Basabe, a middle infielder from the same level.

The Red Sox’ acquisition of Sale comes after days of buildup and speculation that the Nationals would acquire the ace lefty. Nope: he’s Boston bound.

Sale, 27, has pitched in the majors over parts of seven seasons. He owns a career 74-50 record with a 3.00 ERA and a 1,244/260 K/BB ratio in 1,110 innings. The lefty will earn $12 million in 2017, then has a club option for 2018 worth $12.5 million with a $1 million buyout as well as a 2019 club option worth $13.5 million with a $1 million buyout. Relative to what he would earn if he were a free agent today, Sale’s remaining salary is a bargain.

Which is why Boston is giving up a hefty load of prospects to get him. Moncada slumped after a callup to Boston late last season, but he was ranked the number one prospect by Baseball America in its midseason prospect evaluations. The infielder, who has played second and third base, is 21 and hit a combined .294/.407/.511 with 15 homers, 62 RBIs and 45 stolen bases over 106 games in high Class A and Double-A last year.

Kopech, 20, was the Sox’ first round pick in the 2014 draft, going 33rd overall. The righty topped out at high-A ball last season, posting a 2.25 ERA in 11 starts and striking out an astounding 82 batters in 52 innings. He has velocity out the yang — he reached 105 m.p.h. in a minor league game last season — but ran into some off-the-field trouble last year, fracturing his hand in a fight with a teammate last March. In 2015 he was suspended for 50 games after testing positive for a stimulant.

The White Sox trade of Sale is inspired by a number of factors. The largest, of course, being the club’s continued sputtering despite several seasons in a row of loading up on veterans for a playoff run that never materialized. With the club now committed to rebuilding, Sale was the most attractive player they could market given his talent, age and team-friendly contract. It’s also worth noting that Sale clashed with White Sox brass on a number of occasions last year, vocally opposing the team’s handling of the Adam and Drake LaRoche Affair and, later in the season, getting suspended after he took a blade to the club’s throwback uniforms before a game, shredding them because did not want to wear them. Because, he said, they itched. So, OK.

For the Red Sox part: they’re going for it once again, with Dave Dombrowski doing what he always seems to do: make blockbuster trades.


Jeff Samardzija to undergo MRI on right shoulder

Denis Poroy/Getty Images

Update (12:58 AM ET): Per Henry Schulman of the San Francisco Chronicle, Samardzija has been diagnosed with a strained pectoral muscle. He’ll be shut down for a week. That’s good news for the Giants, considering the alternatives.


Giants starter Jeff Samardzija will undergo an MRI on his ailing right shoulder, according to NBC Sports Bay Area. The right-hander struggled in a minor league game on Wednesday, surrendering a pair of home runs and hitting a batter. Overall this spring, Samardzija has given up 15 runs (13 earned) on 17 hits (six homers) and seven walks with seven strikeouts in 11 innings.

This may mean Samardzija won’t be ready for the start of the regular season. Derek Holland would likely replace Samardzija in the rotation. Holland had been competing for the No. 5 spot in the Giants’ rotation.

Samardzija led the National League in losses last season with 15, also posting a 4.42 ERA with a 205/32 K/BB ratio in a league-high 207 2/3 innings. Since becoming a starter, Samardzija has been able to avoid injury, making 32 or 33 starts in each of the last five seasons.